• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低度恶性非霍奇金淋巴瘤的预后:受累部位数量、绝对淋巴细胞计数及血清免疫球蛋白水平的相关性

Prognosis in low grade non-Hodgkin's lymphoma: relevance of the number of sites involved, absolute lymphocyte count and serum immunoglobulin level.

作者信息

Parker D, Alison D L, Barnard D L, Child J A, Dovey G, Farish J, Norfolk D R, O'Brien C J, Parapia L A, Sharp J

机构信息

Clinical Oncology Unit, Bradford University, UK.

出版信息

Hematol Oncol. 1994 Jan-Feb;12(1):15-27. doi: 10.1002/hon.2900120104.

DOI:10.1002/hon.2900120104
PMID:8194840
Abstract

Eighty-eight patients with low grade non-Hodgkin's lymphoma were followed for a median period of 63 months. Sixty-eight per cent of the group were centrocytic/centroblastic B cell lymphomas by the updated Kiel classification. Fifty-one (58 per cent) of the patients were stage IV by the Ann Arbor classification. In 18 of these patients the bone marrow was the only site of extranodal involvement. Univariate survival analysis showed that the sum of involved sites was more discriminatory than Ann Arbor stage. Analysis by site of involvement showed that the liver and other intraabdominal sites were associated with worse survival than involvement of peripheral lymph nodes. Bone marrow and spleen involvement were not significantly associated with short survival. Increasing age at presentation was strongly associated with shorter survival and was also inversely correlated with serum albumin. Both low absolute lymphocyte count (< 1.0 x 10(9)/l), low serum IgG level (< 10 g/l) and low total immunoglobulins on presentation were significantly associated with short survival. Multivariate analysis showed that age, serum albumin and number of involved sites gave the best survival prediction. The sum of involved sites, immunoglobulin level and absolute lymphocyte count may be useful objective markers of prognosis in low-grade non-Hodgkin's lymphoma.

摘要

88例低度非霍奇金淋巴瘤患者接受了为期63个月的中位随访。根据更新后的基尔分类,该组68%为中心细胞/中心母细胞B细胞淋巴瘤。根据安阿伯分类,51例(58%)患者为IV期。在这些患者中,有18例骨髓是结外受累的唯一部位。单因素生存分析显示,受累部位总数比安阿伯分期更具鉴别力。按受累部位分析表明,肝脏和其他腹腔内部位受累与外周淋巴结受累相比,生存期更差。骨髓和脾脏受累与生存期短无显著相关性。就诊时年龄增加与生存期缩短密切相关,且与血清白蛋白呈负相关。就诊时绝对淋巴细胞计数低(<1.0×10⁹/L)、血清IgG水平低(<10g/L)和总免疫球蛋白低均与生存期短显著相关。多因素分析显示,年龄、血清白蛋白和受累部位数量对生存期的预测效果最佳。受累部位总数、免疫球蛋白水平和绝对淋巴细胞计数可能是低度非霍奇金淋巴瘤预后的有用客观指标。

相似文献

1
Prognosis in low grade non-Hodgkin's lymphoma: relevance of the number of sites involved, absolute lymphocyte count and serum immunoglobulin level.低度恶性非霍奇金淋巴瘤的预后:受累部位数量、绝对淋巴细胞计数及血清免疫球蛋白水平的相关性
Hematol Oncol. 1994 Jan-Feb;12(1):15-27. doi: 10.1002/hon.2900120104.
2
Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group.非霍奇金淋巴瘤的骨髓受累:淋巴结与骨髓形态学不一致的临床意义。内布拉斯加淋巴瘤研究组
J Clin Oncol. 1990 Jul;8(7):1163-72. doi: 10.1200/JCO.1990.8.7.1163.
3
Serum immunoglobulins in non-Hodgkin's lymphoma patients.
Coll Antropol. 2010 Jun;34(2):407-11.
4
[Centroblastic and centrocytic centroblastic malignant lymphomas, predominantly splenic (or primary of the spleen). Anatomo-clinical study of 17 cases].[中心母细胞性和中心细胞性中心母细胞性恶性淋巴瘤,主要累及脾脏(或脾脏原发性)。17例病例的解剖学-临床研究]
Bull Cancer. 1987;74(4):437-53.
5
[Tumors of lymphoid and hematopoietic tissue of spleen: a clinicopathologic analysis of 53 cases].脾脏淋巴造血组织肿瘤:53例临床病理分析
Zhonghua Bing Li Xue Za Zhi. 2017 Nov 8;46(11):775-781. doi: 10.3760/cma.j.issn.0529-5807.2017.11.008.
6
[Detection of soluble interleukin-2 receptor in the serum of patients with non-Hodgkin's lymphoma].[非霍奇金淋巴瘤患者血清中可溶性白细胞介素-2受体的检测]
Med Clin (Barc). 1998 Jul 11;111(5):161-7.
7
Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study Group.非霍奇金淋巴瘤基尔分类的临床及预后相关性:基尔淋巴瘤研究组前瞻性多中心研究结果
Hematol Oncol. 1984 Jul-Sep;2(3):269-306. doi: 10.1002/hon.2900020306.
8
[Retrospective analysis of the clinical relevance of the Kiel classification of malignant non-Hodgkin's lymphomas (author's transl)].恶性非霍奇金淋巴瘤基尔分类临床相关性的回顾性分析(作者译)
Strahlentherapie. 1977 Apr;153(4):222-8.
9
Progress in the management of high risk non-Hodgkin's lymphomas. 10 years of experience of the 3rd Medical Department of Hanusch Hospital, Vienna.
Klin Wochenschr. 1985 Jul 15;63(14):619-26. doi: 10.1007/BF01732856.
10
[Prognostic significance of the histological classification and staging for patients with a malignant non-Hodgkin lymphoma].[恶性非霍奇金淋巴瘤患者组织学分类和分期的预后意义]
Ned Tijdschr Geneeskd. 1993 Apr 17;137(16):815-20.

引用本文的文献

1
Ratio of peripheral blood absolute lymphocyte count to absolute monocyte count at diagnosis is associated with progression-free survival in follicular lymphoma.滤泡性淋巴瘤诊断时外周血绝对淋巴细胞计数与绝对单核细胞计数之比与无进展生存期相关。
Int J Hematol. 2014 Jun;99(6):737-42. doi: 10.1007/s12185-014-1576-0. Epub 2014 Apr 23.
2
A pooled analysis of three studies evaluating genetic variation in innate immunity genes and non-Hodgkin lymphoma risk.对评估固有免疫基因遗传变异与非霍奇金淋巴瘤风险的三项研究进行的汇总分析。
Br J Haematol. 2011 Mar;152(6):721-6. doi: 10.1111/j.1365-2141.2010.08518.x. Epub 2011 Jan 20.